Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

OptimizeRx (OPRX) Change in Receivables (2016 - 2026)

OptimizeRx's Change in Receivables history spans 16 years, with the latest figure at $5.5 million for Q4 2025.

  • On a quarterly basis, Change in Receivables fell 53.82% to $5.5 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$460000.0, a 121.22% decrease, with the full-year FY2025 number at -$460000.0, down 121.22% from a year prior.
  • Change in Receivables hit $5.5 million in Q4 2025 for OptimizeRx, up from -$1.3 million in the prior quarter.
  • Over the last five years, Change in Receivables for OPRX hit a ceiling of $12.0 million in Q4 2024 and a floor of -$6.4 million in Q1 2024.
  • Historically, Change in Receivables has averaged $756705.4 across 5 years, with a median of $509500.0 in 2023.
  • Biggest five-year swings in Change in Receivables: soared 415.99% in 2023 and later plummeted 2402.64% in 2024.
  • Tracing OPRX's Change in Receivables over 5 years: stood at $4.1 million in 2021, then grew by 12.26% to $4.6 million in 2022, then surged by 108.88% to $9.6 million in 2023, then grew by 25.25% to $12.0 million in 2024, then plummeted by 53.82% to $5.5 million in 2025.
  • Business Quant data shows Change in Receivables for OPRX at $5.5 million in Q4 2025, -$1.3 million in Q3 2025, and $792000.0 in Q2 2025.